LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 520
Next
>>
>
1 to 25 of 12982 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
MCF7	Alvocidib	0.04	uM	LJP6	1	A18	72	hr	1389	1324	5147	0.2572	-0.0251
MCF7	GW843682X	0.04	uM	LJP6	2	B18	72	hr	1389	5070	5447	0.9306	0.9284
MCF7	CP466722	0.04	uM	LJP5	3	I12	72	hr	1389	6478	6038	1.0728	1.0674
MCF7	CP724714	0.04	uM	LJP5	3	A12	72	hr	1389	5230	6038	0.8661	0.8689
MCF7	Alvocidib	0.04	uM	LJP6	3	A18	72	hr	1389	1636	5740	0.2850	0.0832
MCF7	GW843682X	0.04	uM	LJP6	1	B18	72	hr	1389	4095	5147	0.7956	0.7721
MCF7	Sorafenib	0.04	uM	LJP6	2	B12	72	hr	1389	5724	5447	1.0507	1.0508
MCF7	CP466722	0.04	uM	LJP5	1	I12	72	hr	1389	6117	5772	1.0597	1.0572
MCF7	CP724714	0.04	uM	LJP5	1	A12	72	hr	1389	5249	5772	0.9093	0.9096
MCF7	AZD7762	0.04	uM	LJP6	3	L06	72	hr	1389	1929	5740	0.3360	0.1740
MCF7	Sorafenib	0.04	uM	LJP6	1	B12	72	hr	1389	4484	5147	0.8712	0.8592
MCF7	Alvocidib	0.04	uM	LJP6	2	A18	72	hr	1389	1933	5447	0.3548	0.1825
MCF7	AT-7519	0.04	uM	LJP6	2	K06	72	hr	1389	5687	5447	1.0439	1.0440
MCF7	AT-7519	0.04	uM	LJP6	3	K06	72	hr	1389	5080	5740	0.8849	0.8841
MCF7	Seliciclib	0.04	uM	LJP5	3	J06	72	hr	1389	6077	6038	1.0064	1.0060
MCF7	AZD8055	0.04	uM	LJP6	3	A12	72	hr	1389	1466	5740	0.2554	0.0267
MCF7	AT-7519	0.04	uM	LJP6	1	K06	72	hr	1389	5493	5147	1.0672	1.0700
MCF7	Sorafenib	0.04	uM	LJP6	3	B12	72	hr	1389	5350	5740	0.9320	0.9323
MCF7	AZD8055	0.04	uM	LJP6	1	A12	72	hr	1389	1326	5147	0.2576	-0.0243
MCF7	AZD8055	0.04	uM	LJP6	2	A12	72	hr	1389	1941	5447	0.3563	0.1850
MCF7	AZD7762	0.04	uM	LJP6	1	L06	72	hr	1389	2020	5147	0.3925	0.2192
MCF7	AZD7762	0.04	uM	LJP6	2	L06	72	hr	1389	2012	5447	0.3693	0.2067
MCF7	Seliciclib	0.04	uM	LJP5	1	J06	72	hr	1389	5915	5772	1.0247	1.0239
MCF7	HG-5-113-01	0.04	uM	LJP5	1	B12	72	hr	1389	5066	5772	0.8776	0.8769
MCF7	GW843682X	0.04	uM	LJP6	3	B18	72	hr	1389	4520	5740	0.7874	0.7796

<
<<
Previous
Page 1 of 520
Next
>>
>
1 to 25 of 12982 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)